Llwytho...
ADAPTIVE PHASE-I STUDY OF OROS-METHYLPHENIDATE TREATMENT OF ADHD WITH EPILEPSY
OBJECTIVE: To pilot a randomized controlled trial of OROS-Methylphenidate (MPH) to treat ADHD plus epilepsy. METHOD: Thirty-three patients, 6–18 years, taking antiepileptic drugs and with a last seizure 1–60 months prior were assigned to a maximum daily dose of 18, 36, or 54mg of OROS-MPH in a doubl...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2010
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2902631/ https://ncbi.nlm.nih.gov/pubmed/20493783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yebeh.2010.02.022 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|